» Articles » PMID: 35766735

Cloning, Expression and Seroreactivity of the Recombinant Lipopolysaccharide Assembly Protein - D (LptD) from Bartonella Bacilliformis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective.: To evaluate in silico and at the serological level the antigenic potential of the recombinant extracellular domain of the lipopolysaccharide assembly protein - D (LptD) of Bartonella bacilliformis (dexr_LptD).

Materials And Methods.: Through in silico analysis, we selected a B. bacilliformis protein with antigenic and immunogenic potential. The selected protein gene was cloned into Escherichia coli TOP10 and expressed in Escherichia coli BL21 (DE3) pLysS. Recombinant protein was expressed using isopropyl-β-D-1-thiogalactopyranoside (IPTG) and induction conditions were optimized. Finally, it was purified with Ni-IDA resin (His60 Ni Superflow) and a Western Blot assay was conducted.

Results.: In silico, the selected protein was LptD because it is located in the outer membrane and is antigenic and immunogenic. Optimized conditions for dexr_LptD induction were 0.5 mM IPTG, 16 hours, TB (Terrific Broth) medium, 3% (v/v) ethanol, 28 ºC, OD600: 1-1.5 and 200 rpm. Purification was carried out under denaturating conditions on a small scale and we obtained 2.6 μg/mL of partially purified dexr_LptD. The Western Blot assay showed a positive reaction between the sera from patients with Carrión's Disease and dexr_LptD, which shows the antigenicity of dexr_LptD.

Conclusions.: The dexr_LptD shows antigenicity both in silico and at the serological level, these results are the basis for further studies on vaccine candidates against Carrion's Disease.

Citing Articles

Cloning, expression and seroreactivity of the recombinant lipopolysaccharide assembly protein - D (LptD) from Bartonella bacilliformis.

Flores-Nunez A, Ventura G, Bailon H, Marcelo A, Sandoval G, Padilla-Rojas C Rev Peru Med Exp Salud Publica. 2022; 39(1):15-23.

PMID: 35766735 PMC: 11397601. DOI: 10.17843/rpmesp.2022.391.9292.


Carrion's Disease: the Sound of Silence.

Gomes C, Ruiz J Clin Microbiol Rev. 2017; 31(1).

PMID: 29187394 PMC: 5740975. DOI: 10.1128/CMR.00056-17.

References
1.
Angkasekwinai N, Atkins E, Romero S, Grieco J, Chao C, Ching W . An evaluation study of enzyme-linked immunosorbent assay (ELISA) using recombinant protein Pap31 for detection of antibody against Bartonella bacilliformis infection among the Peruvian population. Am J Trop Med Hyg. 2014; 90(4):690-6. PMC: 3973514. DOI: 10.4269/ajtmh.13-0131. View

2.
Yu Z, Zheng H, Zhao X, Li S, Xu J, Song H . High level extracellular production of a recombinant alkaline catalase in E. coli BL21 under ethanol stress and its application in hydrogen peroxide removal after cotton fabrics bleaching. Bioresour Technol. 2016; 214:303-310. DOI: 10.1016/j.biortech.2016.04.110. View

3.
Dalsass M, Brozzi A, Medini D, Rappuoli R . Comparison of Open-Source Reverse Vaccinology Programs for Bacterial Vaccine Antigen Discovery. Front Immunol. 2019; 10:113. PMC: 6382693. DOI: 10.3389/fimmu.2019.00113. View

4.
Wang C, Liu Y, Li H, Xu W, Zhang H, Peng X . Identification of plasma-responsive outer membrane proteins and their vaccine potential in Edwardsiella tarda using proteomic approach. J Proteomics. 2011; 75(4):1263-75. DOI: 10.1016/j.jprot.2011.11.001. View

5.
Gomes C, Pons M, Del Valle-Mendoza J, Matsuoka M, Ruiz J . Immunogenic Peptides from Pap31 and SCS-α of : One Step Closer to a Rapid Diagnostic Tool for Carrion's Disease. Pathogens. 2021; 10(8). PMC: 8400886. DOI: 10.3390/pathogens10080917. View